|
1
|
Cao Y, Mao X, Sun C, Zheng P, Gao J, Wang
X, Min D, Sun H, Xie N and Cai J: Baicalin attenuates global
cerebral ischemia/reperfusion injury in gerbils via anti-oxidative
and anti-apoptotic pathways. Brain Res Bull. 85:396–402. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kristián T and Siesjö BK: Calcium in
ischemic cell death. Stroke. 29:705–718. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Love S: Oxidative stress in brain
ischemia. Brain Pathol. 9:119–131. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Choi DW and Rothman SM: The role of
glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu
Rev Neurosci. 13:171–182. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang J, Upadhyay UM and Tamargo RJ:
Inflammation in stroke and focal cerebral ischemia. Surg Neurol.
66:232–245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shamloo M, Rytter A and Wieloch T:
Activation of the extracellular signal-regulated protein kinase
cascade in the hippocampal CA1 region in a rat model of global
cerebral ischemic preconditioning. Neuroscience. 93:81–88. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mehta SL, Manhas N and Raghubir R:
Molecular targets in cerebral ischemia for developing novel
therapeutics. Brain Res Rev. 54:34–66. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu S, Levine SR and Winn HR: Targeting
ischemic penumbra: Part I-from pathophysiology to therapeutic
strategy. J Exp Stroke Transl Med. 3:47–55. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ogata K and Kosaka T: Structural and
quantitative analysis of astrocytes in the mouse hippocampus.
Neuroscience. 113:221–233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pekny M and Nilsson M: Astrocyte
activation and reactive gliosis. Glia. 50:427–434. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Swanson RA, Ying W and Kauppinen TM:
Astrocyte influences on ischemic neuronal death. Curr Mol Med.
4:193–205. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mohanty P, Aljada A, Ghanim H, Hofmeyer D,
Tripathy D, Syed T, Al-Haddad W, Dhindsa S and Dandona P: Evidence
for a potent antiinflammatory effect of rosiglitazone. J Clin
Endocrinol Metab. 89:2728–2735. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Escribano L, Simón A-M, Pérez-Mediavilla
A, Salazar-Colocho P, Del Río J and Frechilla D: Rosiglitazone
reverses memory decline and hippocampal glucocorticoid receptor
down-regulation in an Alzheimer's disease mouse model. Biochem
Biophys Res Commun. 379:406–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yi JH, Park SW, Brooks N, Lang BT and
Vemuganti R: PPARgamma agonist rosiglitazone is neuroprotective
after traumatic brain injury via anti-inflammatory and
anti-oxidative mechanisms. Brain Res. 1244:164–172. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Q, Hu W, Meng B and Tang T: PPAR γ
agonist rosiglitazone is neuroprotective after traumatic spinal
cord injury via anti-inflammatory in adult rats. Neurol Res.
32:852–859. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo Y, Yin W, Signore AP, Zhang F, Hong Z,
Wang S, Graham SH and Chen J: Neuroprotection against focal
ischemic brain injury by the peroxisome proliferator-activated
receptor-gamma agonist rosiglitazone. J Neurochem. 97:435–448.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Al Rouq F and El Eter E: PPAR-γ activator
induces neuroprotection in hypercholesterolemic rats subjected to
global cerebral ischemia/reperfusion injury: In vivo and in vitro
inhibition of oxidative stress. Exp Gerontol. 51:1–7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Longa EZ, Weinstein PR, Carlson S and
Cummins R: Reversible middle cerebral artery occlusion without
craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bederson JB, Pitts LH, Germano SM,
Nishimura MC, Davis RL and Bartkowski HM: Evaluation of
2,3,5-triphenyltetrazolium chloride as a stain for detection and
quantification of experimental cerebral infarction in rats. Stroke.
17:1304–1308. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimamura N, Matchett G, Solaroglu I,
Tsubokawa T, Ohkuma H and Zhang J: Inhibition of integrin αvbeta3
reduces blood-brain barrier breakdown in focal ischemia in rats. J
Neurosci Res. 84:1837–1847. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Strong K, Mathers C and Bonita R:
Preventing stroke: Saving lives around the world. Lancet Neurol.
6:182–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vexler ZS, Tang XN and Yenari MA:
Inflammation in adult and neonatal stroke. Clin Neurosci Res.
6:293–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Willis CL: Glia-induced reversible
disruption of blood-brain barrier integrity and neuropathological
response of the neurovascular unit. Toxicol Pathol. 39:172–185.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Q, Tang XN and Yenari MA: The
inflammatory response in stroke. J Neuroimmunol. 184:53–68. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pickering M and O'Connor JJ:
Pro-inflammatory cytokines and their effects in the dentate gyrus.
Prog Brain Res. 163:339–354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaushal V and Schlichter LC: Mechanisms of
microglia-mediated neurotoxicity in a new model of the stroke
penumbra. J Neurosci. 28:2221–2230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barone FC and Parsons AA: Therapeutic
potential of anti-inflammatory drugs in focal stroke. Expert Opin
Investig Drugs. 9:2281–2306. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Batti L and O'Connor JJ: Tumor necrosis
factor-alpha impairs the recovery of synaptic transmission from
hypoxia in rat hippocampal slices. J Neuroimmunol. 218:21–27. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Anderson CM and Swanson RA: Astrocyte
glutamate transport: Review of properties, regulation and
physiological functions. Glia. 32:1–14. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chu K, Lee ST, Sinn DI, Ko SY, Kim EH, Kim
JM, Kim SJ, Park DK, Jung KH, Song EC, et al: Pharmacological
Induction of ischemic tolerance by glutamate transporter-1 (EAAT2)
upregulation. Stroke. 38:177–182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei J, Pan X, Pei Z, Wang W, Qiu W, Shi Z
and Xiao G: The beta-lactam antibiotic, ceftriaxone, provides
neuroprotective potential via anti-excitotoxicity and
anti-inflammation response in a rat model of traumatic brain
injury. J Trauma Acute Care Surg. 73:654–660. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Azbill RD, Mu X and Springer JE: Riluzole
increases high-affinity glutamate uptake in rat spinal cord
synaptosomes. Brain Res. 871:175–180. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harvey BK, Airavaara M, Hinzman J, Wires
EM, Chiocco MJ, Howard DB, Shen H, Gerhardt G, Hoffer BJ and Wang
Y: Targeted over-expression of glutamate transporter 1 (GLT-1)
reduces ischemic brain injury in a rat model of stroke. PLoS One.
6:e221352011. View Article : Google Scholar : PubMed/NCBI
|
